BIODESIX INC

BDSXSEC EDGAR

Services-Medical Laboratories(DE)CIK: 1439725

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	$71.3M	$49.1M	$38.2M	$54.5M	$45.6M
Research and Development Expense	$9.6M	$10.0M	$13.1M	$12.8M	$10.8M
Selling, General and Administrative Expense	$80.5M	$67.4M	$61.5M	$50.5M	$34.9M
Operating Expenses	$105.8M	$90.4M	$88.8M	$95.4M	$68.5M
Operating Income (Loss)	-$34.5M	-$41.3M	-$50.6M	-$40.9M	-$22.9M
Interest Expense	$8.3M	$9.5M	$8.1M	$4.5M	$7.6M
Nonoperating Income (Expense)	-$8.4M	-$10.8M	—	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$97.2M	$99.1M	$92.9M	$76.1M	$121.1M
Assets, Current	$39.5M	$39.7M	$53.3M	$43.6M	$86.1M
Cash and Cash Equivalents, at Carrying Value	$26.2M	$26.3M	$43.1M	$32.7M	$62.1M
Accounts Receivable, after Allowance for Credit Loss, Current	$8.6M	$7.7M	$5.1M	$3.7M	$15.3M
Liabilities	$76.4M	$94.5M	$72.3M	$56.4M	$79.9M
Liabilities, Current	$14.3M	$33.4M	$22.8M	$29.0M	$32.1M
Long-term Debt	$50.0M	$40.0M	$40.1M	$30.1M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$48.6M	-$22.9M	-$45.0M	-$28.2M	-$21.4M
Net Cash Provided by (Used in) Investing Activities	-$3.4M	-$23.1M	-$3.5M	-$2.5M	-$2.9M
Net Cash Provided by (Used in) Financing Activities	$52.0M	$29.1M	$58.9M	$1.3M	$81.1M
Payments to Acquire Property, Plant, and Equipment	$3.2M	$22.9M	$3.3M	$2.2M	$1.9M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)